Barbara White, M.D. [clinicaltrials_resource:2b839759747ff014ecfe7ba2f386aa86]
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528 [clinicaltrials:NCT00116168]Long-Term Follow-Up Study of Psoriasis Patients [clinicaltrials:NCT00131066]Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis [clinicaltrials:NCT00192517]Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) [clinicaltrials:NCT00299819]A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545 [clinicaltrials:NCT00472758]
overall official [clinicaltrials_vocabulary:overall-official]
Barbara White, M.D. [clinicaltrials_resource:2b839759747ff014ecfe7ba2f386aa86]
Bio2RDF identifier
2b839759747ff014ecfe7ba2f386aa86
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2b839759747ff014ecfe7ba2f386aa86
affiliation [clinicaltrials_vocabulary:affiliation]
email [clinicaltrials_vocabulary:email]
raibleD@medimmune.com
last name [clinicaltrials_vocabulary:last-name]
Barbara White, M.D.
phone [clinicaltrials_vocabulary:phone]
301-398-0000
role [clinicaltrials_vocabulary:role]
Study Director
identifier
clinicaltrials_resource:2b839759747ff014ecfe7ba2f386aa86
title
Barbara White, M.D.
@en
type
label
Barbara White, M.D. [clinicaltrials_resource:2b839759747ff014ecfe7ba2f386aa86]
@en